Home Infusion Plus

Option Care provides comprehensive home infusion services to combat serious infections in patients of all ages. Our anti-infective therapy and services help avoid hospitalizations for many infections that can be safely treated at home.

Proven partner in the fight against serious infection

Our broad service coverage ensures that nearly all acute and chronic care patients across the United States can receive the product supply and health coverage support they need quickly.1

We coordinate anti-infective home infusion care quickly to avoid costly hospital admissions

Time-­saving intake coordination2
Option Care specialists confirm insurance benefits and respond to referral requests within 2 hours.* We start therapy for 9 out of 10 patients who are referred to us, and we can start a targeted therapy at a patient’s home within 24 hours, which helps avoid hospitalizations. This high start rate is achieved by facilitating insurance verification, connecting patients to appropriate financial assistance resources, and reviewing coverage and care with patients.

Individualized care plans
Many infections can be safely treated at home, and we customize anti-infective treatment plans to the specific needs of each AI patient. Our pharmacists conduct a full case review and consult with prescribing physicians and healthcare providers as needed to ensure appropriate antibiotic choices or suggest treatment adjustments. We adapt the established protocols to meet your requirements while helping to achieve optimal treatment outcomes.

Clinical monitoring and reporting
Specialized AI nurses monitor and track patients throughout home infusion treatment. Option Care notifies physicians of adverse changes in patient status and provides routine updates at intervals designated by the physician or healthcare provider. Option Care has local data available to help prescribers gauge and improve quality of care, and to avoid health system penalizations.

Long-term support and education
Option Care infusion nurses counsel patients and caregivers on anti-infectives home infusion, self-care and monitoring tools, and proper hygiene maintenance. When it comes to infections, our dedication to optimal outcomes allows patients to transition sooner from IV antibiotics to oral medicines. Option Care provides 24/7 patient support with experienced clinicians.

*Average time from receipt of all necessary documentation.

There are up to 4 million avoidable hospital admissions each year.”

—Agency for Healthcare Research and Quality3

Hospital readmissions are substantially lower than the national average

Less than 1% of Option Care anti-infectives home infusion patients are readmitted to the hospital — a substantial reduction compared to the national average.4 Our multidisciplinary approach helps us achieve this remarkable outcome. Pharmacists monitor patient care and intervene when necessary. It is estimated that every pharmacist intervention avoids an average of $1,623 in costs. 5

Option Care treats the most common infection diagnoses

†Interventions include prevention and management of drug-drug interactions and adverse drug reactions, as well as therapy changes, including adjustments to dose, frequency, route, or treatment duration. ‡National average based on standards established by the Agency for Healthcare Research and Quality. Data were collected January to November 2010 using the Healthcare Cost and Utilization Project (HCUP), the largest payer healthcare database, and included inpatient, ambulatory surgery, and emergency department treatment. §These outpatient home, clinic, and ambulatory infusion suite data are based on event reports entered by an Option Care employee from September 2012 to August 2013, regardless of payer.

1. Option Care coverage area data. STI: PopStats, Austin, TX. Calculated 04/28/14. 2. Data on file, Option Care. 3. Agency for Healthcare Research and Quality. Four million hospital admissions potentially unnecessary. AHRQ News and Numbers. November 3, 2010. Rockville, MD.­and-­numbers/11310.html. Accessed January 5, 2015. 4. Review of Option Care patient data, October 2009-February 2011. Based on an average 39,978 patients per month. 5. Retrospective review (August 2012-­January 2013) of patients who received home infusions of parenteral vancomycin and aminoglycosides. Of 9,223 total patients, 257 were randomly selected and reviewed for pharmacist interventions performed. 6. Review of Option Care patient data, September 2012-­August 2013. Based on review of 45,917 anti-­infective patients. 7. Elixhauser A, Steiner C. Readmissions to U.S. hospitals by diagnosis, 2010. http://www.hcup-­ Healthcare Cost and Utilization Project, Agency for Healthcare Research